Overview

A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Status:
Terminated
Trial end date:
2017-11-03
Target enrollment:
Participant gender:
Summary
This Phase IIa, randomized, double-blind, placebo-controlled, parallel group study will evaluate the safety, efficacy and pharmacodynamics of basmisanil in adult participants with severe motor impairment following an ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Hoffmann-La Roche